PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 132 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,330,774 | -39.6% | 5,415,514 | 0.0% | 1.91% | -33.1% |
| Q2 2023 | $149,576,497 | +41.4% | 5,415,514 | +17.7% | 2.85% | +29.2% |
| Q1 2023 | $105,818,377 | +170.0% | 4,600,799 | +28.1% | 2.20% | +175.5% |
| Q4 2022 | $39,188,567 | +11.3% | 3,591,986 | -14.0% | 0.80% | -1.5% |
| Q3 2022 | $35,211,000 | -7.2% | 4,176,837 | -12.9% | 0.81% | -17.1% |
| Q2 2022 | $37,924,000 | -66.6% | 4,794,499 | 0.0% | 0.98% | -58.3% |
| Q1 2022 | $113,534,000 | +27.7% | 4,794,499 | +84.4% | 2.35% | +81.0% |
| Q4 2021 | $88,914,000 | +186.1% | 2,599,822 | +48.2% | 1.30% | +176.8% |
| Q3 2021 | $31,075,000 | -80.3% | 1,753,695 | -50.0% | 0.47% | -80.3% |
| Q2 2021 | $157,412,000 | +73.3% | 3,507,390 | 0.0% | 2.38% | +67.5% |
| Q1 2021 | $90,841,000 | +23.5% | 3,507,390 | -3.9% | 1.42% | +14.8% |
| Q4 2020 | $73,585,000 | +10.4% | 3,650,069 | +7.1% | 1.24% | -23.1% |
| Q3 2020 | $66,645,000 | +11.5% | 3,408,961 | +0.8% | 1.60% | -4.5% |
| Q2 2020 | $59,747,000 | +218.1% | 3,383,208 | +27.2% | 1.68% | +108.0% |
| Q1 2020 | $18,782,000 | +8.3% | 2,660,392 | +8.1% | 0.81% | +23.5% |
| Q4 2019 | $17,343,000 | +89.4% | 2,459,988 | +222.7% | 0.65% | +20.2% |
| Q3 2019 | $9,155,000 | – | 762,283 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |